Benadryl (diphenhydramine) is primarily metabolized in the liver, where enzymes break it down through a process called N-demethylation. About 72% of an oral dose reaches your bloodstream after passing through the liver’s initial filtering, and the drug takes roughly 9 hours to drop to half its concentration in a healthy adult. The rest of the journey involves several liver enzymes, genetic variables, and age-related differences that determine how quickly your body clears it.
What Happens After You Swallow It
When you take Benadryl by mouth, it’s absorbed through your digestive tract and passes through the liver before entering general circulation. This first pass through the liver immediately breaks down a portion of the dose. After that initial filtering, about 72% of the original dose makes it into your bloodstream in active form. The drug typically reaches its peak concentration in your blood within 2 to 3 hours.
The Liver Enzymes That Break It Down
The liver uses a family of enzymes called cytochrome P450 to dismantle diphenhydramine. The primary workhorse is an enzyme called CYP2D6, which strips methyl groups off the drug’s nitrogen atom in a reaction called N-demethylation. CYP2D6 has the highest affinity for diphenhydramine among 14 different enzyme variants tested, meaning it latches onto the drug more readily than any other.
Three additional enzymes play supporting roles: CYP1A2, CYP2C9, and CYP2C19. These are lower-affinity enzymes, meaning they contribute to metabolism but handle less of the total workload. If CYP2D6 is occupied or impaired, these backup enzymes pick up some of the slack.
An interesting wrinkle: diphenhydramine is not just broken down by CYP2D6, it also inhibits the same enzyme. That means the drug competes with other medications that rely on CYP2D6 for their own metabolism. If you take Benadryl alongside another drug processed by the same enzyme, either one could linger in your system longer than expected.
What the Body Turns It Into
As liver enzymes strip down diphenhydramine, they produce two main metabolites. The first is diphenylmethoxyacetic acid (DPMA), created when the drug is oxidized. The second is diphenhydramine-N-oxide (DPHMNO), formed through a different oxidation pathway. Both of these breakdown products are less pharmacologically active than the original drug and are eventually filtered out by the kidneys into urine.
How Age Changes the Timeline
Your age has a dramatic effect on how fast your body clears Benadryl. A study comparing three age groups found significant differences in both half-life and clearance rate:
- Children: average half-life of 5.4 hours, with a clearance rate of about 49 mL/min/kg
- Young adults: average half-life of 9.2 hours, with a clearance rate of about 23 mL/min/kg
- Older adults: average half-life of 13.5 hours, with a clearance rate of about 12 mL/min/kg
In practical terms, older adults clear diphenhydramine at roughly one quarter the speed of children. This explains why Benadryl tends to cause more pronounced drowsiness, confusion, and dry mouth in older people. The drug simply stays in their system much longer, sometimes more than twice as long as it does in a younger adult. Liver enzyme activity naturally declines with age, and reduced blood flow to the liver further slows the process.
Genetic Differences in Metabolism
Because CYP2D6 does most of the heavy lifting, genetic variations in this enzyme can meaningfully change your experience with Benadryl. People inherit different numbers of working copies of the CYP2D6 gene, and the number of copies determines how fast the enzyme works.
Most people have two functional copies. But roughly 1% to 2% of the U.S. population carries three or more active copies, making them ultrarapid metabolizers. These individuals break down diphenhydramine unusually fast, which can lead to a paradoxical reaction: instead of feeling drowsy, they become agitated or excited. Case reports describe ultrarapid metabolizers experiencing restlessness and stimulation after taking standard doses. The leading theory is that their abnormally high CYP2D6 activity converts diphenhydramine into a metabolite that causes excitation rather than sedation.
On the other end of the spectrum, people with fewer functional copies of CYP2D6 (poor metabolizers) break down the drug more slowly. For them, a standard dose may produce stronger or longer-lasting sedation than expected. An estimated 5% to 10% of the population falls into this category, depending on ethnic background.
How It Leaves the Body
Once liver enzymes have converted diphenhydramine into its metabolites, the kidneys handle the final stage. The metabolites are water-soluble enough to be filtered into urine and excreted. Only a small fraction of the original drug leaves the body unchanged. The bulk of what shows up in urine consists of DPMA and other breakdown products. With a half-life of 7 to 12 hours in adults, most of a single dose is effectively cleared within 2 to 3 days, though this stretches considerably in older adults or anyone with reduced liver or kidney function.